IT1255470B - Compounds active as inhibitors of HMG-CoA reductase enzyme - Google Patents

Compounds active as inhibitors of HMG-CoA reductase enzyme

Info

Publication number
IT1255470B
IT1255470B ITMI921854A ITMI921854A IT1255470B IT 1255470 B IT1255470 B IT 1255470B IT MI921854 A ITMI921854 A IT MI921854A IT MI921854 A ITMI921854 A IT MI921854A IT 1255470 B IT1255470 B IT 1255470B
Authority
IT
Italy
Prior art keywords
hmg
inhibitors
coa reductase
reductase enzyme
compounds active
Prior art date
Application number
ITMI921854A
Other languages
Italian (it)
Inventor
Gabriele Norcini
Cesare Casagrande
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to ITMI921854A priority Critical patent/IT1255470B/en
Publication of ITMI921854A0 publication Critical patent/ITMI921854A0/en
Publication of ITMI921854A1 publication Critical patent/ITMI921854A1/en
Application granted granted Critical
Publication of IT1255470B publication Critical patent/IT1255470B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Compounds of general formula I <IMAGE> in which the radicals have the meaning specified in the description, which are useful as drugs in the treatment of antihypercholesterolaemia, in the treatment of atherosclerosis and hyperlipidaemia are described.
ITMI921854A 1992-07-30 1992-07-30 Compounds active as inhibitors of HMG-CoA reductase enzyme IT1255470B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI921854A IT1255470B (en) 1992-07-30 1992-07-30 Compounds active as inhibitors of HMG-CoA reductase enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921854A IT1255470B (en) 1992-07-30 1992-07-30 Compounds active as inhibitors of HMG-CoA reductase enzyme

Publications (3)

Publication Number Publication Date
ITMI921854A0 ITMI921854A0 (en) 1992-07-30
ITMI921854A1 ITMI921854A1 (en) 1994-01-30
IT1255470B true IT1255470B (en) 1995-11-02

Family

ID=11363776

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921854A IT1255470B (en) 1992-07-30 1992-07-30 Compounds active as inhibitors of HMG-CoA reductase enzyme

Country Status (1)

Country Link
IT (1) IT1255470B (en)

Also Published As

Publication number Publication date
ITMI921854A1 (en) 1994-01-30
ITMI921854A0 (en) 1992-07-30

Similar Documents

Publication Publication Date Title
HU0004863D0 (en)
PL346660A1 (en) Method for treating atherosclerosis employing an ap2 inhibitor and combination
AU6613896A (en) Chemical compounds
EP0433842A3 (en) 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them
EP0352864A3 (en) Compounds active as inhibitors of the cholesterol biosynthesis
MY136037A (en) Biphenyl pyrimidone lp-pla2 inhibitors
WO1996009827A3 (en) Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
DK0649425T3 (en) Pyridino-, pyrrolidino- and azepino-substituted oxymers useful as anti-atherosclerosis and anti-hypercholester esters
AU5820294A (en) Endothelin converting enzyme inhibitors
MXPA04004372A (en) Heterocyclic derivatives of glycinamide and their medical use.
ES2090177T3 (en) DERIVATIVES OF PIRROL.
NO996206L (en) Farnesyltransferase inhibitors in combination with HMG COA reductase inhibitors for the treatment of cancer
BG105003A (en) Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer
AU6212398A (en) 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia
IT1255470B (en) Compounds active as inhibitors of HMG-CoA reductase enzyme
AU7529200A (en) Composition useful for conditioning sludge derived from the treatment of an aqueous medium and uses thereof
WO1996026728A3 (en) Use of moxonidine for the treatment of atherosclerosis
NZ501368A (en) 3Beta-27-dihydroxy-5-cholesten-7-one and its use in pharmaceutical compositions
EP0930360A3 (en) Microbiological diagnostical device

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970612